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Introduction
Cell surface receptors play an important role in sensing the 
local environment and transducing this information to the 
cell interior where signaling responses can be appropriately 
controlled and coordinated. A large portion of Food and 
Drug Administration (FDA)-approved drugs target cell sur-
face proteins, and future treatments that focus on blocking 
ligand–receptor binding events may have important impli-
cations in preventing disease and pathogen infections.1 
Membrane-spanning receptors, however, are notoriously 
difficult to study, as the absence of a plasma membrane can 
lead to solubility issues and changes in native structure and 
function.2 In addition to this, extracellular binding events 
are typically low affinity (K
D
 in the micromolar to milli-
molar range) and there are several thousand known genes 
encoding cell surface receptors in the human genome.3–7 
There is therefore a need for assays that take account of the 
biochemical difficulties while also incorporating high-
throughput elements to ensure efficient screening.8
One large-scale biochemical approach to identify low-
affinity extracellular protein interactions involves testing for 
direct binding events between soluble recombinant proteins 
that comprise the ectodomain regions of cell surface recep-
tors. To increase binding avidity, these proteins are fused 
with domains that promote multimerization and can 
be systematically screened against one another in a simple 
plate-based format or by using microarray technology to spot 
ectodomains in a defined pattern onto slides. These methods 
have successfully identified extracellular protein binding 
events in many biological contexts, including pathogen–host 
cell interactions.9–11 Screening of recombinant proteins is 
resource-intensive and library design is often restricted to 
receptors that have a single contiguous region exposed on the 
external-facing surfaces of the cell. This means that many 
multipass membrane proteins and multisubunit complexes 
are not generally suitable for this approach.
The use of cell-based assays provides an opportunity to 
overcome some of these challenges, allowing receptors to 
be studied within the context of the cell surface microenvi-
ronment. For example, mass spectrometry-based techniques 
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Abstract
Extracellular protein interactions coordinate cellular responses with their local environment and have important roles in 
pathogen invasion and disease. Due to technical challenges associated with studying binding events at the cell surface, the 
systematic and reliable identification of novel ligand–receptor pairs remains difficult. Here, we describe the development 
of a cell-based assay using large-scale transient transfections and high-content imaging (HCI) to detect extracellular binding 
events. We optimized the parameters for efficient transfection of human cells with cDNA plasmids encoding full-length 
cell surface receptors in 384-well plates. Using a range of well-characterized structurally diverse low-affinity cell surface 
interactions, we show that transfected cells probed with highly avid ligands can be used to successfully identify ligand–
receptor pairs using an HCI platform and automated image analysis software. To establish the high-throughput potential of 
this approach, we also screened a pool of ligands against a collection of 2455 cell surface expression clones and found that 
known ligand–receptor interactions could be robustly and consistently detected across the library using this technology.
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have been used on living cells where probes with chemi-
cally derived tags are able to covalently capture and purify 
endogenous receptors12,13 and CRISPR/Cas9 technology 
can generate genome-wide libraries of knockout cells that 
can be sorted by simple readouts, such as a loss of pathogen 
invasion14 or a reduction in the binding of a soluble recom-
binant ectodomain.15 CRISPR/Cas9-based tools can also be 
used in the gain of binding studies where the transcriptional 
activation of endogenous genes (CRISPRa) has been 
employed to overexpress all cell surface proteins in the 
human genome, successfully identifying receptors bound 
by monoclonal antibodies and highly avid ligands.16
As an alternative gain of binding approach, transient 
transfection of cDNAs encoding full-length receptors can 
promote receptor overexpression on the surface of cells. 
More classical approaches using expression libraries gener-
ated from cell/tissue sources have been very successful, but 
iterative rounds of selection and screening on complex 
pools decrease throughput.17 Therefore, more high-through-
put implementations of this approach are required, as shown 
by the recent commercialization of a cell microarray, where 
expression plasmids spotted onto slides and reverse trans-
fected into cells are used to identify receptors bound by a 
labeled probe.18,19 Here, we aimed to set up a cell-based 
assay where cDNA-induced overexpression of cell surface 
receptors could be used to screen for extracellular interac-
tions in 384-well plates with high-content imaging (HCI) 
and automated image analysis software. Recombinant 
ectodomains screened against transiently transfected cells 
were pentamerized to increase the binding avidity of poten-
tially weak cell surface interactions and GripTite HEK293 
cells were used to ensure adherence following multiple 
wash steps in immunofluorescence procedures. We imple-
mented this approach in a high-throughput screening format 
using a collection of 2455 human cell surface expression 
clones and found that known ligand–receptor interactions 
were detected efficiently across the library using this tech-
nology. Importantly, this method provides a platform to 
study biochemically challenging receptors within the con-
text of an intact plasma membrane.
Materials and Methods
Recombinant Protein Production and 
Normalization
The ectodomain regions of extracellular proteins were codon-
optimized for expression in human cells and synthesized with 
flanking NotI (5′) and AscI (3′) restriction sites (GeneArt, 
ThermoFisher, Waltham, MA). Ectodomain sequences were 
subsequently cloned into mammalian expression plasmids 
containing C-terminal tags (Cd4d3+4-COMP-blac-3xFLAG-
6xHis).20 Regions 3 and 4 of rat Cd4 were used as an anti-
genic sequence, and a cartilage oligomeric matrix protein 
(COMP) peptide was used to pentamerize ectodomains, 
producing highly avid protein complexes. The β-lactamase 
enzyme and the 6xHis-tag were used for normalization and 
purification, respectively. All ectodomains were expressed 
with their endogenous signal peptide sequences, except 
LPHN1 and GPR64, which were designed to include an 
exogenous signal peptide.16,21
Recombinant proteins were produced as soluble secreted 
ectodomains by transiently transfecting HEK293 cells as 
described previously.22,23 Briefly, HEK293E cells grown in 
FreeStyle media (Gibco, ThermoFisher, Waltham, MA) 
supplemented with 50 µg/mL G418 and 1% (v/v) heat-
inactivated fetal bovine serum (FBS; Sigma, St Louis, 
MO) were prepared in 100 mL suspensions at a density of 
2.5 × 105 cells/mL. After 24 h, cells were transiently trans-
fected and cultured for 6 days before supernatants were 
harvested and filtered through a 0.2 μm filter. Supernatants 
were either concentrated with a 20 k MWCO spin concen-
trator (Sartorius, Gottingen, Germany) or, for His-tag puri-
fications, passed through a HisTrap HP column on an 
AKTApure (GE Healthcare, Chicago, IL). Purified pro-
teins were buffer exchanged into phosphate-buffered saline 
(PBS) using PD midiTrap G-25 columns (GE Healthcare) 
and stored at 4 °C with 2 mM sodium azide. Recombinant 
protein ectodomains were normalized using β-lactamase 
enzyme activity assays through the hydrolysis of the colo-
rimetric β-lactamase substrate nitrocefin.23 In brief, 30 μL 
of serially diluted supernatants, or purified proteins, was 
incubated with 60 μL of 125 μg/mL nitrocefin at room 
temperature for 20 min. The rate of nitrocefin hydrolysis 
was measured at an absorbance of 485 nm with a Spark 
microplate reader (Tecan, Mannedorf, Switzerland).
Antibody Production, Purification, and 
Fluorescent Labeling
The hybidroma cell line OX68 (ECACC 94011007) secretes 
a mouse IgG2a monoclonal antibody that recognizes 
domains 3 and 4 of rat Cd4. Hybridomas were adapted to 
serum-free media (Hybridoma-SFM; Gibco) and the super-
natant harvested and filtered through a 0.2 μm filter. The 
OX68 antibody was purified with a 5 mL HiTrap Protein G 
HP column using 20 mM sodium phosphate, pH 7.0 (bind-
ing buffer), and 0.1 M glycine, pH 2.7 (elution buffer), on an 
AktaExpress (GE Healthcare). Eluted fractions of 500 µL 
were collected in 96-deep-well plates containing 40 µL of 
1 M Tris, pH 9.0, to neutralize solutions. Fractions were 
subsequently dialyzed against PBS and stored at 4 °C before 
labeling. The OX68 antibody was labeled with a 20× molar 
excess of Alexa Fluor 488 NHS Ester (Invitrogen Molecular 
Probes, Carlsbad, CA) in 0.1 M sodium bicarbonate, pH 
8.5, for 1 h at room temperature. Reactions were quenched 
at a final concentration of 0.1 M Tris, pH 8, for 5 min at 
room temperature and immediately dialyzed against PBS. A 
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preservative of 2 mM sodium azide was added to fluores-
cently labeled antibodies and aliquots frozen at –20 °C.
cDNA Library Storage and Plasmid Purification
A collection of expression plasmids encoding full-length 
cell surface receptors were purchased from OriGene Tech-
nologies (Rockville, MD) and GeneCopoeia (Rockville, 
MD) and stored as bacterial glycerol stocks (Suppl. Table 
S1). Origene clones were a mixture of TrueClone untagged 
cDNA clones derived from human cDNA libraries, 
TrueORF tagged ORF clones (Myc-DDK tag), and 
untagged ORF clones synthesized by the company. 
GeneCopeia provided expression-ready untagged ORF 
clones. All ORF clones are sequence verified by their 
respective companies. Origene’s TrueClones are assessed 
for the completeness of the open reading frame and com-
pared with an associated reference. Our aim was to accu-
mulate cDNAs encoding the longest isoforms. Competent 
Escherichia coli were produced in-house using the Inoue 
method from library efficiency DH5α cells (Invitrogen, 
Carlsbad, CA).24 The creation of bacterial stocks was 
adapted from an automated approach to DNA library prep-
aration.25 Briefly, competent cells were thawed and 20 µL 
was distributed into each well of a 96-well PCR plate 
(Thermo Fisher Scientific, Waltham, MA). While on ice, 
40–60 ng of plasmid DNA was added to each well and 
incubated for 30 min, heat-shocked for 1 min at 42 °C, and 
then placed back on ice for a further 2 min. For cells trans-
formed with plasmids containing an ampicillin-resistant 
gene, 5 µL was directly transferred to an 8-well agar plate 
supplemented with appropriate antibiotics. Heat-shocked 
cells transformed with a kanamycin-resistant plasmid were 
incubated with 200 µL of TB buffer at 37 °C and plated 3 h 
later. Single colonies were picked and added to 96-deep-
well dishes containing 1.5 mL of TB buffer and incubated 
for a further 18–20 h at 37 °C. Bacterial cultures were 
stored in barcoded 0.3 mL FluidX tubes (Brooks Life 
Sciences, Manchester, UK) at –80 °C at a final concentra-
tion of 40% glycerol.
To purify plasmid DNA, glycerol stocks were thawed 
and 5 µL distributed to 4× 24-deep-well plates containing 
LB media with appropriate antibiotics and incubated over-
night at 37 °C. A QIAVac 96 vacuum manifold and QIAprep 
96 filter plates were used to miniprep DNA in accordance 
with the manufacturer’s instructions (Qiagen, Hilden, 
Germany). The only difference was that 4× 24-well plates 
were centrifuged for 50 min at high speed after the addition 
of neutralization buffer to pellet the flock, enabling super-
natants to be effectively distributed into the QIAprep 96 
filter plate. The elution step was also performed twice with 
100 µL of EB buffer. Concentrations ranged from ~50 to 
300 µg/mL and multiple freeze–thaws of plasmid DNA 
were avoided.
Cell Culture and Transfections
GripTite HEK293 cells (Invitrogen) were cultured in 
DMEM+GlutaMAX-I (Gibco) containing 10% (v/v) heat-
inactivated FBS (Sigma), 500 µg/mL G418, and 100 µM 
nonessential amino acids (Gibco) at 37 °C in a humidified 
atmosphere of 5% CO
2
. To increase cell adherence, black-
walled TC-treated 384-well plates (Corning, New York, NY) 
were incubated for 1 h with 25 µL of a 25 µg/mL PEImax 
40K solution (pH 7) (Polysciences, Inc., Warrington, PA).26 
To remove PEImax from the wells, plates were centrifuged 
upside down at 1500 rpm and left to dry under the tissue 
culture hood. GripTite cells at a confluency of 50%–80% 
were detached from culture flasks in accordance with the 
manufacturer’s instructions and diluted into complete media 
at a concentration of 2 × 105 cells/mL. An automatic pipette 
was used to distribute 50 µL of cell suspension into each 
well (10,000 cells) and plates were centrifuged for 2 min at 
100 rcf before being placed back at 37 °C for 24 h. Lipid-
based transfections in a 384-well format were performed 
with a Viaflo 384 (Integra, Plainsboro, NJ) using a channel 
pipetting head capable of handling 0.5–12.5 µL. Two 384-
well plates were prepared: a DNA plate (plate 1) and a trans-
fection reagent plate (plate 2). To account for dead volume, 
a 1.5× volume reaction was created for each well. In plate 1, 
plasmid DNA was transferred from a stock cDNA library 
plate and mixed 1:1 with Optimem+GlutaMax-I (Gibco) 
(3.75 µL total). A master mix of Optimem+Glutamax-I and 
Lipofectamine 2000 (Invitrogen) was aliquoted into plate 2 
(scale-up from single reaction: 2.5 µL Optimem + 0.15 µL 
transfection reagent). The Viaflo 384 was used to transfer 
3.75 µL of transfection reagent from plate 2 into plate 1 and 
programmed to gently mix solutions six times, at a volume 
of 4 µL. This process can be efficiently repeated for multiple 
cDNA plates. After 20 min at room temperature, 5 µL of the 
cDNA/transfection mix was added to cells simultaneously 
using the 384-channel pipette. Plates were covered with a 
gas-permeable seal, placed back in the 37 °C incubator, and 
left for 40–48 h before fixation and staining protocols.
Immunofluorescence Fixation and Staining
For each step, an automatic pipette was used to add liquid to 
384-well plates, while multichannel aspirations were used 
to remove liquid. So as not to disrupt the cells, ~20–25 µL 
was left in the bottom of wells after each aspiration. 
Transfected cells incubated for 40–48 h in 384-well plates 
were collected from the 37 °C incubator and excess media 
aspirated from the wells. Supernatants containing recombi-
nant ectodomains, or purified proteins diluted into 
DMEM+GlutaMAX-I, were preheated to 37 °C and a vol-
ume of 25 µL was added to each well (as 20–25 µL remains 
in the wells, recombinant proteins were diluted 1:1 with 
conditioned media). Plates were centrifuged for 2 min at 
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100 rcf and placed back in the 37 °C incubator for 2 h. 
Plates were then washed two times with 50 µL of PBS that 
had been prewarmed to 37°C, followed by fixation with 
25 µL of 8% paraformaldehyde/PBS (Alfa Aeser, Haverhill, 
MA) for 20 min at room temperature (final concentration, 
~4% paraformaldehyde). Cells were immediately washed 
two times with 50 µL of PBS and incubated with 25 µL of 
1% bovine serum albumin (BSA)/PBS (diluted from aseptic 
30% BSA; Sigma) containing 6.25 µg/mL Alexa488-
labeled OX68 antibody and 5 µg/mL Hoechst-33342 
(Invitrogen Molecular Probes) for 1.5 h at room tempera-
ture (final concentrations, ~3.125 and 2.5 µg/mL, respec-
tively). The antibody incubation was followed by three PBS 
washes and plates were stored in the refrigerator protected 
from light until the images were ready to be acquired.
High-Content Imaging and Analysis
The Cellomics Arrayscan VTI HCS Reader (Thermo Fisher 
Scientific) was used as a high-content screening platform to 
image 384-well plates. For each well, four fields of view in 
two fluorescent channels (Hoechst-33342 and Alexa488) 
were sequentially acquired using the 20× objective and 
BGRFR filter sets (BGRFR_386_23 and BGRFR_485_20). 
We found that using a higher magnification objective and 
capturing a section of the well (4 out of a possible 25 fields) 
worked best for the detection of cells while enabling effi-
cient data acquisition timings. In channel 1 (Ch1), 
Hoechst-33342 staining was used to visualize cell nuclei, 
while Alexa488 detection in channel 2 (Ch2) was used to 
identify extracellular ligand–receptor binding events. The 
Cell Health Profiling BioApplication within the HCS Studio 
Cell Analysis Software was used for all downstream analy-
sis. Images in Ch1 and Ch2 were preprocessed for the 
removal of background fluorescence. Hoechst-stained 
nuclei in Ch1 were segmented and defined as primary 
objects and a region of interest was used to capture signals 
in Ch2 across the whole cell. A fixed threshold in Ch2 was 
also applied so that only high-intensity Alexa488 signals 
were used for target identification. The aim was to calculate 
the percentage of cells that possess Ch2 target average 
intensity readings above a manually defined response limit. 
Well features were recorded and represent population statis-
tics for all cells selected for analysis. Heatmaps of the data 
were created using R (www.r-project.org) and RStudio 
(www.rstudio.com).
Results
Optimization of High-Content Imaging and 
Automated Image Analysis to Identify Cell 
Surface Interactions in a 384-Well Format
Development of the HCI approach to study extracellular pro-
tein interactions required the optimization of experimental 
procedures and image acquisition protocols across 384-well 
plates. The general workflow is summarized in Figure 1A, 
where the interaction between CD200 and the CD200 recep-
tor (CD200R) was used as a model low-affinity receptor–
ligand interaction to establish experimental parameters for a 
cell-based interaction assay.27 We wanted to test multiple 
conditions that would be important for the immunodetection 
of extracellular interactions, including cell type, transfection 
efficiency, cell fixation, and antibody concentration.
For the transfection array, expression plasmids encoding 
full-length CD200 were complexed with Lipofectamine and 
distributed simultaneously into wells using a 384-channel 
pipette. Transiently transfected cells overexpressing cell 
surface CD200 were subsequently tested for binding with a 
highly avid probe containing the ectodomain region of 
CD200R. Importantly, the ectodomain is fused with a pen-
tamerization domain that increases the binding avidity of 
typically weak extracellular interactions to facilitate their 
detection.2,23 To minimize the disruption of epitopes, fixa-
tion steps were performed after the addition of avid ectodo-
mains, and permeabilization/detergent-containing wash 
steps were also excluded from the protocol to maintain the 
integrity of the plasma membrane. To assess adherence, cell 
nuclei were stained with Hoechst-33342, and to detect 
extracellular binding events, we used the anti-Cd4 mono-
clonal antibody (OX68) that recognizes the Cd4 tag on the 
recombinant probe. Images from two fluorescence channels 
were acquired using the Arrayscan-VTI HCI system.
We established that GripTite HEK293 cells were an ideal 
cell line for assay development as they combined high rates 
of transfection efficiency, while being sufficiently adherent 
to withstand multiple plate washing steps. By manually 
inspecting images across the 384-well plate, we determined 
that ~3.125 µg/mL OX68-Alexa488 could effectively detect 
cell surface interactions across multiple wells while exhibit-
ing low levels of background fluorescence (Fig. 1B). Three 
concentrations of fixative were tested, and brighter, more 
consistent fluorescence signals in Hoechst-33342-labeled 
nuclei were observed with 4% paraformaldehyde (Fig. 1C). 
To establish optimal transfection conditions, we used vary-
ing cDNA–Lipofectamine ratios and found that transfection 
reagent volumes between 0.1 and 0.2 µL and cDNA concen-
trations between ~30 and 125 ng resulted in high numbers 
of Alexa488-positive cells (Fig. 1D). Importantly, ectodo-
main binding was absent in mock-transfected cells, while 
fluorescence signals in populations of cells overexpressing 
CD200 localized to the plasma membrane (Fig. 1D).
With these optimized conditions established, we sought 
to set up an automated image-based analysis with the ulti-
mate aim of increasing the scale of detection. To identify the 
percentage of cells in a well that had gained the ability to 
bind an avid probe, two fluorescence channels were acquired 
and analyzed simultaneously using an integrated workflow 
(Cell Health Profiling BioApplication; HCS Studio). Images 
acquired in the Hoechst channel were used to segment and 
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Figure 1. Optimization of a 384-well extracellular interaction assay using HCI. (A) Schematic of the general workflow for detecting extracellular 
receptor–ligand binding using CD200–CD200R as a model interaction. (1) A plasmid encoding the CD200R ectodomain regions in-frame with a 
C-terminal Cd4 tag was transiently transfected into HEK293E cells, and 6 days later recombinant proteins were collected. The ectodomains were 
expressed with a peptide tag that promotes pentamer formation to increase the binding avidity of weak interactions. (2) Adherent GripTite cells 
plated in a 384-well format were transfected with cDNAs encoding full-length CD200. (3) After 40–48 h, cells overexpressing CD200 on their 
cell surface were probed with CD200R proteins. Binding was detected using an Alexa488-labeled antibody (OX68) that recognizes the rat Cd4 
domains 3 + 4 (Cd4d3+4) tag fused to CD200R ectodomains. Images of individual wells in a 384-well plate were acquired using an HCI system. 
(B) Testing of multiple parameters for the immunodetection of extracellular interactions. Areas of 4 × 4 wells were treated with increasing 
concentrations of Lipofectamine and CD200 encoding cDNA. Cells were fixed with different paraformaldehyde concentrations as indicated and 
stained with serially diluted Alexa488-labeled OX68 antibody. (C) The effect of paraformaldehyde fixation on the detection of nuclei. Acquired 
images of Hoechst-33342 stained nuclei in cell populations fixed with 1%, 2%, and 4% paraformaldehyde. Scale bar = 100 µm. (D) Alexa488-
labeled antibodies can be used to detect recombinant protein binding to transfected cell populations. The amounts of cDNA and Lipofectamine 
(Lipo) per transfection reaction are indicated. Zoomed-in regions depict surface staining of cells. Scale bar = 100 µm.
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mark the boundaries of individual nuclei (primary objects) 
(Fig. 2A). Nuclear objects were then used to define a region 
of interest surrounding the cell, and within this area, a fixed 
fluorescence threshold was set to detect and measure high-
intensity Alexa488 signals (Fig. 2A). By setting a cellular 
response limit, the percentage of cells characterized by 
strong OX68-Alexa488 antibody staining could then be cal-
culated (Fig. 2B). By defining this cellular state, it is there-
fore possible to separate ligand-bound and unbound cell 
populations. An important parameter dictated by transfec-
tion efficiency was the requirement to plate cells at ~50%–
60% confluency, transfect, and wait 48 h before ectodomain 
screening. We imaged wells at high magnification to try to 
accurately segment nuclei and found that a large proportion 
of nuclei can be successfully separated, as shown by the 
image segmentation mask in channel 1 (Fig. 2C). We did 
observe some over- and undersegmentation across larger 
data sets, especially in overgrown regions that were chal-
lenging to segment, but using heatmaps for comparison, we 
found that nuclei count remained relatively consistent 
between wells (Fig. 2D); as a consequence, cell number is 
estimated, rather than absolute. The target mask in channel 2 
is able to detect ligand-bound cells, even when transfection 
efficiencies are poor (Fig. 2C). We used this approach to 
show how varying the amount of plasmid DNA and transfec-
tion reagent affected signal readouts, which were trans-
formed into heatmaps to facilitate analysis (Fig. 2D).
High-Content Imaging Can Be Used to Identify 
Low-Affinity Ligand–Receptor Interactions 
between Different Architectural Classes of 
Receptor
Using this image-based screening approach, we sought to 
verify a selection of low-affinity cell surface interactions 
between structurally varied and functionally diverse recep-
tors. Seven known receptor–ligand pairs were chosen, with 
their previously reported K
D
 values depicted (Fig. 3A).17,27–33 
This included interactions involving type I and type II single-
pass cell surface receptor proteins, glycosylphosphatidylino-
sitol (GPI)-anchored proteins, and multispanning membrane 
proteins. As some recombinant proteins are difficult to 
express in sufficient amounts for large-scale screening 
approaches, we also wanted to test the sensitivity of this 
assay to varying the concentrations of the soluble binding 
probe. Supernatants containing β-lactamase tagged ligands 
were concentrated, normalized, and serially diluted down the 
plate (Fig. 3B, Suppl. Fig. S1A). We found that we could 
confidently identify six out of seven receptor–ligand pairs, 
including the extremely weak (K
D
 > 80 µM) CD97–CD55 
interaction (Fig. 3B). Images overlaid with target identifica-
tion masks showed that weak Alexa488 signals cannot be 
readily distinguished from background fluorescence and 
therefore the Juno–Izumo interaction was difficult to detect 
using this technique (Fig. 3C). Even though cells remained 
attached across all wells, as established by the cell nuclei 
count, the percentage of cells with high-fluorescence signals 
in the Alexa488 channel decreased upon dilution of recombi-
nant ectodomains. For optimal screening, we calculated the 
final concentration of avid probes to be in the range of ~10–
20 µg/mL. To ensure that this assay was sufficiently robust at 
detecting ligand–receptor interactions, we manually 
inspected images across the plate and found that all wells 
consistently matched with image-based analysis measure-
ments (Suppl. Fig. S1B).
Depending on the number of plates that need to be 
screened, high-content screening can be resource-intensive 
in terms of materials, and may also require long acquisition 
times and large amounts of data storage. To try and increase 
the throughput of assay conditions, five recombinant 
ectodomains were purified, normalized, and combined in 
pools to test their ability to maintain receptor binding speci-
ficities under these conditions (Fig. 4A, Suppl. Fig. S2A). 
The same ligand–receptor pairings were tested as before, 
with the addition of the CD47–SIRPG interaction, which 
has been shown to have a binding affinity of ~23 µM.34 As 
shown previously, incubations with individual recombinant 
ectodomains led to high Alexa488 signals in a subpopula-
tion of cells in accordance with the cell surface overexpres-
sion of their respective receptor pair (Fig. 4A). Importantly, 
specificity was maintained when avid ligands were pooled 
in three different mixes; combining two, three, and five dis-
tinct ectodomains, which was supported by manually 
inspecting images in the Alexa488 channel (Fig. 4B, Suppl. 
Fig. S2B). These results provided further confidence that 
the pooling of recombinant ectodomains can be used to 
increase the throughput of large-scale extracellular protein 
interaction screens.
Large-Scale Screening of Ligand–Receptor Pairs 
Using a Cell Surface cDNA Expression Library
While we could employ image-based analysis to success-
fully identify ligand–receptor interactions in small focused 
studies, we next sought to determine if this approach could 
be used on a scale that would encompass the thousands of 
different proteins that have been identified at the surface of 
human cells.3–5,7 We therefore compiled a list of 2455 
cDNAs encoding full-length human membrane-localized 
receptors (Suppl. Table S1). Most of the expression plas-
mids are untagged, but ~250 are C-terminally Myc-FLAG 
tagged. There is some redundancy within the plasmid 
library, with 54 genes represented by two or three different 
plasmids, although the majority of these were present as 
tagged and untagged forms. We have established that mul-
tiple probes can be used to identify interactions, and so we 
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Figure 2. Extracellular interactions can be identified using automated image analysis tools. (A) Summary of image processing workflow. 
Hoechst-stained nuclei in channel 1 (Ch1) were segmented and defined as primary objects (cyan). In channel 2 (Ch2), a circular (Circ) region of 
interest (ROI) was created, extending out from the primary object to include an area covered by the whole cell (green). A fixed fluorescence 
threshold was set to further define the cellular area used for Ch2 Alexa488 measurements, so that only pixels above this intensity were kept 
for analysis and included in the target identification mask (red). (B) Measuring the percentage of cells in a population bound by recombinant 
probes. (i) When no Alexa488 fluorescence threshold is defined, all pixels within the ROI were included in the target identification mask and 
used for analysis. (ii) Defining the fixed fluorescence threshold allows cells to be categorized into two populations: those that were not covered 
by the Ch2 mask (–ve = 0), and those that were covered and therefore have an average pixel intensity equal to or greater than the defined 
threshold (+ve). (iii) A response level was then set to calculate the percentage of cells in the population characterized by high Alexa488 signals. 
(C) Example segmentation and target identification masks. Images of CD200–CD200R extracellular interactions overlaid with masks for the 
segmentation of Hoechst-stained nuclei (Ch1: cyan) and Alexa488 target identification (Ch2: red). Scale bar = 100 µm. (D) Image-based analysis 
detected variations in transfection efficiencies between wells. Heatmaps represent the average number of nuclei counted per field (i.e., primary 
objects) and the percentage of cells bound by CD200R ectodomains based on the automated detection of high Alexa488 signals (% Cells High). 
Cells were transfected with different concentrations of lipofectamine (Lipo) and CD200 cDNA.
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Figure 3. Automated image-based screening and analysis detected low-affinity cell surface interactions between different ligand–
receptor classes. (A) Schematic of known extracellular interaction partners used as positive controls. The architectural receptor 
subclasses are indicated together with the reported affinity measurements (K
D
 values) for each interaction. (B) Ligand-bound cell 
populations were consistently detected across 384-well plates. Cells were transfected with 62.5 ng of cDNAs encoding full-length cell 
surface receptors using 0.15 µL of Lipofectamine per well. Avid recombinant ectodomains were incubated with transiently transfected 
cells as depicted in the 384-well layout. Concentrated supernatant (SUP) containing highly avid ectodomain probes was normalized 
and serially diluted down the plate (1:2 to 1:128). Cells incubated with complete media were used as negative control wells (–). 
Heatmaps depict the average number of nuclei per field and the percentage of cells that are characterized as having high Alexa488 
fluorescence signals. (C) The application of target identification masks depends on the signal intensity of ligand–receptor interactions. 
Representative images for ligand–receptor pairs are shown with and without channel 2 target identification masks (red). Scale bar = 
100 µm.
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pooled four different proteins corresponding to the ectodo-
mains CD200R, LPHN1, ZP2, and GPR64. CD200R and 
LPHN1 were included as positive controls since they have 
known ligands. ZP2 and GPR64 are both orphan receptors: 
ZP2 is localized to the zona pellucida that surrounds oocytes 
and is suggested to bind an undefined ligand expressed on 
sperm,35 and GPR64 belongs to the family of adhesion 
G-protein-coupled receptors (GPCRs) and is essential for 
male fertility.36 HEK293 cells were individually transfected 
with the library of 2455 cDNAs arrayed together with two 
Figure 4. Pooling recombinant ectodomains increases screening throughput. (A) Ligand–receptor pairs are detected using pooled 
ectodomain probes. Cells were transfected with cDNAs encoding full-length cell surface receptors at 62.5 ng per well using  
0.15 µL of Lipofectamine for each reaction. Mock-transfected cells and empty vector transfections were used as negative control 
wells. Recombinant ectodomains were concentrated using his-tag purifications and normalized with β-lactamase enzymatic activity. 
Recombinant protein ectodomains for LPHN1, CD200R1, CD47, CD58, and CD55 were incubated in wells individually and in pools 
(mixes 1–3). Measurements depict the percentage of cells bound by avid probes (% Cells High). (B) Representative Alexa488 channel 
images for the detection of ligand–receptor pairs using three distinct mixes of avid probes. Scale bar = 100 µm.
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columns of control cDNAs on nine 384-well plates; these 
control transfections were used to establish the Alexa488 
fixed fluorescence threshold and the cellular response limit 
(Fig. 5A). Using a stringent cellular response limit, we 
could clearly distinguish negative and positive ligand-
bound cell populations in control wells (Fig. 5B). During 
image acquisition, fields of view that had failed to autofo-
cus were automatically rejected from downstream analysis. 
When this did occur, it was often a single out-of-focus 
image in a well, and as cell loss was not a problem, we 
could still effectively capture high numbers of nuclei from 
the three remaining fields of view for calculation of down-
stream measurements (Suppl. Fig. S3A). Nuclei counts 
were compared to assess variations in cell attachment across 
plates, and we found that large deviations were relatively 
uncommon (Suppl. Fig. S3B). Images were visually 
checked in wells characterized by having very low cell 
numbers, and these counts could be attributed to the poor 
application of segmentation algorithms, rather than through 
a loss of cell binding (Suppl. Fig. S3C). Across nine plates, 
known interacting partners for CD200R and LPHN1 were 
successfully identified (Fig. 5C). Two distinct cDNAs 
encoding both an untagged and tagged full-length CD200 
were included in the library (plates 1 and 7), and both were 
robustly detected. LPHN1 is known to bind to paralogous 
family members of both the FLRTs and teneurins (TENMs), 
and all three FLRT paralogs were identified.28–30 Of the four 
TENM paralogs in the genome, we detected interactions 
with TENM2 and TENM4, and while TENM3 is a known 
ligand,16 cDNAs encoding this receptor were absent from 
the library. We identified five other plasmids that conferred 
positive binding signals that encoded the receptors ART1, 
MCOLN1, CLEC4M, LILRB3, and PIGR, and these were 
retested in independent confirmation assays with each indi-
vidual binding probe. Both LILRB3 and PIGR overexpress-
ing cells displayed cell surface staining (Suppl. Fig. S3D), 
but upon retesting were found to bind directly to Alexa488-
labeled OX68, and are likely to interact with the constant 
domain of the labeled OX68 mouse IgG.37 Cells transfected 
with plasmids encoding CLEC4M exhibited weak cell sur-
face staining (Suppl. Fig. S3D), but promiscuous binding 
of this receptor across multiple screens was observed, and 
as it is a C-type lectin family member, it may bind to ligands 
modified with carbohydrates. Although ART1 and 
MCOLN1 were detected as positive hits, the pattern of fluo-
rescence did not localize to cell surfaces and instead 
appeared internalized (Suppl. Fig. S3D). We were unable to 
confirm the specificity of binding with individually tested 
recombinant ectodomains and therefore believe these recep-
tors to be false-positive hits. In summary, the identification 
of the known binding partners for CD200R and LPHN1 
demonstrated that this approach can be used to detect 
ligand–receptor interactions on a genome-wide scale, but 
no candidate ligands for either ZP2 or GPR64 ectodomains 
were identified.
Discussion
Here we describe the development of a cell-based assay 
using large-scale transient transfections and HCI to detect 
extracellular binding events between ligand–receptor pairs. 
The assay is simple as only two readouts are measured: the 
total cell number (nuclei count) and the percentage of 
ligand-bound cells within the population. This means that 
images are acquired in two fluorescence channels, and 
because population statistics are recorded—rather than 
individual cell features—less data storage is needed. 
Analysis was performed simultaneously with image acqui-
sition, and we carefully considered the number of fields 
imaged per well to reduce screening time. Due to the sim-
plicity of image processing, this approach should be easily 
performed on most, if not all, HCI systems using either the 
supplied commercial software or open-source image analy-
sis tools such as CellProfiler38 or Fiji.39
We demonstrated that established immunofluorescence 
protocols could be consistently applied across 384-well 
plates for the immunolabeling of recombinant ligands on 
cells. Paraformaldehyde is an appropriate fixative for this 
application since it preserved the epitope on the protein tag 
while maintaining the integrity of the plasma membrane. 
There is evidence that some surface receptors remain 
mobile within the membrane after fixation with 4% parafor-
maldehyde (e.g., GPI-anchored proteins),40 and supplemen-
tation with glutaradehyde40 or glyoxal41 could be considered 
for more complete/quicker fixation of cell membranes.
Here, we used recombinant ectodomains as the probe of 
choice, but as with other cell-based extracellular interaction 
assays, ligands such as peptides and pathogens could also 
be applied, as long as they could be easily detected through 
fluorescent labeling. Incubating recombinant proteins with 
living cells at 37 °C was sufficient to identify most of the 
known interactions tested in this assay; however, cells are 
still metabolically active, and it is known that binding of 
antibodies and ligands can promote receptor internalization. 
We did try incubations at lower temperatures (4 °C), but this 
led to some loss of cell adherence. Future refinements of the 
assay may include the addition of sodium azide, which can 
be used to prevent endocytosis, although the effect on 
GripTite HEK293 cell viability and adhesion would need to 
be established.
The cell-based approach described here to identify extra-
cellular receptor–ligand interactions could have advantages 
over biochemical plate-based studies since we have shown 
that it can be used to identify interactions between architec-
turally diverse receptors. For example, we found that we 
could overexpress a multispanning transmembrane protein 
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Figure 5. Systematic large-scale screening identified expected interactions. (A) Summary of 384-well templates for large-scale 
screening. Negative and positive control wells are located in columns 2 and 13. Positive control wells included a plasmid encoding 
full-length CD200R fused to green fluorescent protein (CD200R-GFP) and wells transfected with varying concentrations of plasmids 
containing full-length cDNAs encoding CD200 and FLRT2; these were used as controls since LPHN1 and CD200R are known to bind 
to FLRT family members (FLRTs) and CD200, respectively. Because of the plate edge effects, wells on the borders of plates were 
excluded from analysis (NA). (B) Positive control interactions were robustly and consistently detected across multiple 384-well plates. 
By measuring the percentage of cells with high Alexa488 fluorescence signals, negative and positive wells were clearly distinguished. 
(C) Large-scale image-based screening can identify extracellular cell surface interactions. Screening was performed using recombinant 
protein ectodomains for LPHN1, CD200R1, GPR64, and ZP2. Rank-ordered receptors bound by avid recombinant ectodomains 
across each of the nine 384-well plates are shown.
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from the adhesion GPCR family (CD97) and confirmed 
binding with a known ligand. We established that we could 
scale the assay to include 2455 cell surface cDNAs and 
identify known interactions consistently across the library. 
Importantly, the number of false positives was low so that 
subsequent confirmation assays could be easily performed. 
To increase throughput, we found that ectodomain regions 
could be pooled, and this will help to save on resources 
since multiple interactions can be tested in a single experi-
ment. However, we did find that large amounts of recombi-
nant protein are required for this approach, much more than 
is required for assays involving the direct binding of recom-
binant ectodomains. This means that this assay may only be 
suitable for proteins that can be expressed and purified in 
large amounts when implemented at scale. Future refine-
ments to reduce the amount of protein required could 
involve further miniaturization in 1536-well microplates, 
which are compatible with many HCI instruments.
The low-affinity interaction between the Juno–Izumo 
receptor–ligand pair was more difficult to detect in this 
assay as fluorescence signals were too weak for automated 
detection using the image analysis protocol described. It is 
possible that Juno’s transport is more tightly regulated by 
the cell, reducing the number of sites presented for Izumo 
binding at the cell surface. Differences in the levels of 
receptor expression or presentation on the plasma mem-
brane are likely to be a source of variation that will affect 
the outcomes of screens and are a major limitation when 
compared with biochemical screens where ectodomain con-
centrations can be directly controlled. Even when receptors 
are expressed highly on cell surfaces, it could also be pos-
sible that the large pentamerization and detection tags on 
recombinant ectodomains impact on the identification of 
interactions through steric hindrance. Low expression of 
receptor pairs, steric hindrance, or simply an absence of a 
receptor-encoded cDNA within the library could account 
for false negatives, and may account for the lack of ZP2 and 
GPR64 novel binding events within the large-scale screen.
In conclusion, here we have described the optimization 
of a protocol for the transfection of cells in a 384-well plate 
format together with an HCI system to detect low-affinity 
extracellular protein interactions at a genome-wide scale.
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